lodoxamide ethyl has been researched along with isospaglumic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldschmidt, P; Luyckx, J | 1 |
Budak, K; Eryilmaz, T; Gündüz, K; Ozkan, M; Uçakhan, O | 1 |
Couturier, C; Goldschmidt, P; Haeffner-Cavaillon, N; Herman, D; Kazatchkine, M | 1 |
Bloch-Michel, E; Denis, D; Di Giovanni, A; Helleboid, L; Lecorvec, M; Sebastiani, A; Tazartes, M; Verin, P | 1 |
Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
2 trial(s) available for lodoxamide ethyl and isospaglumic acid
Article | Year |
---|---|
Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
Topics: Adolescent; Adult; Child; Child, Preschool; Conjunctivitis, Allergic; Dipeptides; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Oxamic Acid; Safety | 1996 |
Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Dipeptides; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxamic Acid; Patient Satisfaction; Treatment Outcome | 1998 |
3 other study(ies) available for lodoxamide ethyl and isospaglumic acid
Article | Year |
---|---|
Effects of lodoxamide (LOD), disodium cromoglycate (DSCG) and N-acetyl-aspartyl-glutamate sodium salt (NAAGA) on ocular active anaphylaxis.
Topics: Anaphylaxis; Animals; Cell Degranulation; Conjunctivitis; Cromolyn Sodium; Dipeptides; Eye; Guinea Pigs; Immunosuppressive Agents; Male; Ophthalmic Solutions; Oxamic Acid | 1996 |
Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Basophil Degranulation Test; Basophils; Cell Degranulation; Complement C5; Cromolyn Sodium; Dipeptides; Enzyme-Linked Immunosorbent Assay; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Ophthalmic Solutions; Oxamic Acid; Piperidines; Recombinant Proteins | 1997 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |